NLRP3 and brain cancer: The expression of ATP7A, ATP7B, DLAT, DLD, FDX1, GLS, LIAS, LIPT1, MTF1, NLRP3, PDHA1, PDHB, and SLC31A1 was higher in brain cancer, colon/colorectal cancer, rhabdoid, rhabdoid, bone cancer, kidney cancer, eye cancer, teratoma, thyroid cancer, leukemia, teratoma, rhabdoid, and fibroblast cell lines, respectively, than in other cancer cell lines.